sorafenib has been researched along with thermozymocidin in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (thermozymocidin) | Trials (thermozymocidin) | Recent Studies (post-2010) (thermozymocidin) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 267 | 1 | 148 |
| Protein | Taxonomy | sorafenib (IC50) | thermozymocidin (IC50) |
|---|---|---|---|
| Serine palmitoyltransferase 2 | Homo sapiens (human) | 0.0001 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbero-Camps, E; Bárcena, C; Colell, A; de Gregorio, E; Fernandez-Checa, JC; García-Ruiz, C; Marí, M; Martinez-Nieto, GA; Morales, A; Moutinho, C; Stefanovic, M; Tutusaus, A; Villanueva, A | 1 |
1 other study(ies) available for sorafenib and thermozymocidin
| Article | Year |
|---|---|
Targeting glucosylceramide synthase upregulation reverts sorafenib resistance in experimental hepatocellular carcinoma.
Topics: Animals; Apoptosis; Blotting, Western; Carcinoma, Hepatocellular; Cell Proliferation; Ceramides; Drug Resistance, Neoplasm; Fatty Acids, Monounsaturated; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glucosyltransferases; Humans; Immunoenzyme Techniques; Immunosuppressive Agents; Liver Neoplasms, Experimental; Male; Mice; Mice, Nude; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Sorafenib; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2016 |